How Exercise Restores Autophagy to Fight Sarcopenic Obesity in Aging
A new review reveals how exercise reactivates cellular cleanup pathways to simultaneously preserve muscle and reduce fat in older adults.
Summary
Sarcopenic obesity — the combination of shrinking muscle and excess body fat — is a growing problem in aging adults that dramatically raises mortality risk. A key hidden driver is impaired autophagy, the cell's internal recycling system, which normally keeps muscles healthy and fat metabolism balanced. Aging, inflammation, and insulin resistance all disrupt autophagy, accelerating muscle loss and fat accumulation. This narrative review examines how different exercise types restore autophagic function through pathways like AMPK/mTOR, TFEB, PGC-1α, and mitophagy. Resistance training favors muscle-building autophagy, aerobic exercise targets fat-clearing processes, and combined training may offer the broadest metabolic benefit. The authors conclude that progressive, moderate-intensity combined exercise is the most promising current strategy for managing sarcopenic obesity, though dedicated randomized controlled trials are still needed.
Detailed Summary
Sarcopenic obesity affects a growing proportion of older adults and carries serious consequences — reduced mobility, metabolic dysfunction, and increased all-cause mortality. Unlike simple obesity or simple muscle loss alone, the combination creates a compounding cycle of functional decline that is difficult to reverse. Understanding the underlying cellular mechanisms is essential for designing effective interventions.
This narrative review from Central South University focuses on autophagy — the cell's quality-control process that clears damaged proteins, dysfunctional mitochondria, and excess lipids. In healthy aging tissue, autophagy keeps skeletal muscle and fat tissue communicating productively. But in sarcopenic obesity, autophagy becomes impaired by chronic low-grade inflammation, insulin resistance, and aging itself, which accelerates both muscle wasting and ectopic fat deposition in a vicious cycle.
The authors synthesize evidence on how exercise modulates key autophagic pathways. The AMPK/mTOR/ULK1 axis acts as a cellular energy sensor that exercise activates to trigger autophagy. TFEB and FoxO transcription factors regulate autophagy gene expression, while PGC-1α links mitochondrial biogenesis to mitophagy — the selective clearance of damaged mitochondria. Sirtuins, the NAD-dependent deacetylases central to longevity biology, also regulate autophagic flux in an exercise-dependent manner.
Different exercise modalities produce distinct autophagic effects. Resistance exercise promotes muscle anabolism alongside selective autophagy processes. Aerobic exercise primarily drives mitophagy and lipophagy, helping clear fat from muscle tissue. High-intensity interval training elicits rapid autophagy responses, though these are recovery-dependent. Combined exercise protocols appear to offer the broadest benefit by simultaneously preserving muscle and reducing adiposity.
The review concludes that long-term, progressive, moderate-intensity combined exercise is the most promising strategy for sarcopenic obesity management. However, robust SO-specific randomized controlled trials are lacking, and future research should integrate dynamic autophagic flux monitoring with phenotype-stratified exercise prescriptions to personalize treatment.
Key Findings
- Impaired autophagy is a central mechanism linking aging, obesity, and muscle loss in sarcopenic obesity.
- Exercise restores autophagic flux through AMPK/mTOR/ULK1, TFEB/FoxO, PGC-1α, sirtuin, and mitophagy pathways.
- Resistance training favors muscle-preserving selective autophagy; aerobic exercise drives mitophagy and lipophagy.
- Combined progressive exercise may simultaneously reduce fat and preserve muscle via complementary autophagy mechanisms.
- No SO-specific randomized controlled trials confirm exercise-autophagy benefits — clinical evidence gap remains large.
Methodology
This is a narrative review synthesizing existing human and experimental literature on autophagy, sarcopenic obesity, and exercise interventions. Authors are from the Department of Physical Education and Center for Sports Rehabilitation at Central South University, China. The review does not involve primary data collection or meta-analytic pooling of effect sizes.
Study Limitations
This summary is based on the abstract only, as the full text is not open access. As a narrative review, it is subject to selection bias and cannot quantify effect sizes across studies. The authors acknowledge that direct randomized controlled trial evidence in sarcopenic obesity populations is lacking, limiting the strength of clinical recommendations.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: